E. Casado

5.5k total citations · 1 hit paper
114 papers, 4.0k citations indexed

About

E. Casado is a scholar working on Oncology, Orthopedics and Sports Medicine and Surgery. According to data from OpenAlex, E. Casado has authored 114 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Oncology, 33 papers in Orthopedics and Sports Medicine and 26 papers in Surgery. Recurrent topics in E. Casado's work include Bone health and osteoporosis research (32 papers), Colorectal Cancer Treatments and Studies (17 papers) and Bone health and treatments (16 papers). E. Casado is often cited by papers focused on Bone health and osteoporosis research (32 papers), Colorectal Cancer Treatments and Studies (17 papers) and Bone health and treatments (16 papers). E. Casado collaborates with scholars based in Spain, United States and France. E. Casado's co-authors include Manuel González-Barón, Paloma Cejas, Juan Ángel Fresno Vara, Cristóbal Belda-Iniesta, Javier de Castro, Jordi Gratacós, Josep Tabernero, M. Larrosa, Jaime Feliú and C. Orellana and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Oncogene.

In The Last Decade

E. Casado

104 papers receiving 3.9k citations

Hit Papers

PI3K/Akt signalling pathw... 2003 2026 2010 2018 2003 500 1000 1.5k

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
E. Casado 1.9k 1.2k 636 589 502 114 4.0k
Thomas Streichert 1.2k 0.6× 594 0.5× 328 0.5× 461 0.8× 242 0.5× 136 3.8k
Kun Wang 1.7k 0.9× 929 0.8× 1.0k 1.6× 1.2k 2.0× 576 1.1× 272 5.4k
Shinya Sato 2.1k 1.1× 1.0k 0.9× 1.1k 1.7× 558 0.9× 522 1.0× 302 5.4k
Gerhard Krönke 2.8k 1.5× 841 0.7× 495 0.8× 454 0.8× 378 0.8× 138 6.3k
Juan José Pérez Ruixo 1.0k 0.5× 1.6k 1.3× 415 0.7× 164 0.3× 505 1.0× 148 3.4k
Yoshiji Yamada 3.6k 1.9× 1.1k 0.9× 792 1.2× 380 0.6× 346 0.7× 220 7.6k
Zsolt Tulassay 2.1k 1.1× 1.6k 1.4× 1.4k 2.3× 808 1.4× 847 1.7× 302 5.9k
Cong Chen 2.5k 1.3× 1.1k 0.9× 594 0.9× 579 1.0× 433 0.9× 181 4.8k
Lili Feng 2.0k 1.1× 414 0.4× 288 0.5× 1.1k 1.9× 255 0.5× 67 5.2k
Jae‐Ho Lee 1.6k 0.9× 585 0.5× 607 1.0× 265 0.4× 403 0.8× 236 3.4k

Countries citing papers authored by E. Casado

Since Specialization
Citations

This map shows the geographic impact of E. Casado's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Casado with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Casado more than expected).

Fields of papers citing papers by E. Casado

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Casado. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Casado. The network helps show where E. Casado may publish in the future.

Co-authorship network of co-authors of E. Casado

This figure shows the co-authorship network connecting the top 25 collaborators of E. Casado. A scholar is included among the top collaborators of E. Casado based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Casado. E. Casado is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Casado, E., et al.. (2025). Los análogos de la PTH/PTHrP como tratamiento osteoanabólico de los pacientes con osteoporosis. Medicina Clínica. 165(4). 107076–107076. 1 indexed citations
2.
Peris, Pilar, M. J. Barceló, P. Aguado, et al.. (2024). Bisphosphonate drug holidays in osteoporosis according to fracture risk profile. Osteoporosis International. 36(2). 245–254. 2 indexed citations
3.
Bonfill, Teresa, et al.. (2023). Prevalence of metabolic acidosis in ileal diversions more than one year after radical cystectomy and associated secondary metabolic effects. Actas Urológicas Españolas (English Edition). 47(8). 494–502.
5.
Domingo, Christian, et al.. (2023). Potential impact of mepolizumab in stepping down anti-osteporotic treatment in corticosteroid-dependent asthma. Frontiers in Pharmacology. 14. 1183156–1183156. 2 indexed citations
6.
Casado, E., et al.. (2023). Transition of patients with metabolic bone disease from paediatric to adult healthcare services: current situation and proposals for improvement. Orphanet Journal of Rare Diseases. 18(1). 245–245. 3 indexed citations
7.
Sánchez‐Delgado, Jordi, Marta Arévalo, Mireia Miquel, et al.. (2023). Osteoporosis and Fragility Fractures in Patients with Liver Cirrhosis: Usefulness of FRAX® as a Screening Tool. Journal of Clinical Medicine. 13(1). 188–188.
9.
11.
Geusens, Piet, Fernando Marín, David L. Kendler, et al.. (2018). Effects of Teriparatide Compared with Risedronate on the Risk of Fractures in Subgroups of Postmenopausal Women with Severe Osteoporosis: The VERO Trial. Journal of Bone and Mineral Research. 33(5). 783–794. 71 indexed citations
12.
Nogués, Xavier, et al.. (2014). Caso clínico a debate: vacaciones terapéuticas, ¿sí o no?. SHILAP Revista de lepidopterología. 6(4). 127–131.
13.
Casado, E., Víctor Moreno, José Javier Sánchez, et al.. (2011). A Combined Strategy of SAGE and Quantitative PCR Provides a 13-Gene Signature that Predicts Preoperative Chemoradiotherapy Response and Outcome in Rectal Cancer. Clinical Cancer Research. 17(12). 4145–4154. 25 indexed citations
14.
Tabernero, Josep, Patrick Schöffski, Federico Rojo, et al.. (2005). Combined anti-EGFR blockade: A phase I pharmacokinetic and molecular pharmacodynamic study of Cetuximab (Erbitux (R)) and Gefitinib (Iressa (R)) in patients with advanced colorectal, head and neck and non-small cell lung cancer expressing the EGFR. Clinical Cancer Research. 11(24). 4 indexed citations
15.
Larrosa, M., Jordi Gratacós, Eugenio Berlanga, et al.. (2003). Administración de calcidiol y valores séricos de 25-OH-D3. ¿Qué pauta clínica utilizar?. 30(10). 548–553. 2 indexed citations
16.
Casado, E., et al.. (2002). Linfadenitis necrosante de Kikuchi-Fujimoto y su asociación con el lupus eritematoso sistémico: descripción de 4 nuevos casos. 29(8). 416–419. 2 indexed citations
17.
Arafat, Waleed, Jesús Gómez-Navarro, Donald J. Buchsbaum, et al.. (2002). Effective single chain antibody (scFv) concentrations in vivo via adenoviral vector mediated expression of secretory scFv. Gene Therapy. 9(4). 256–262. 29 indexed citations
18.
Gumá, Mónica, et al.. (2000). Un sistema de codificación en reumatología. Experiencia de 15 años. 27(3). 88–92. 1 indexed citations
19.
Casado, E., et al.. (1999). Tratamiento con inmunoglobulina intravenosa en la aplasia pura de la serie roja en una paciente con lupus eritematoso sistémico. Medicina Clínica. 112(17). 1 indexed citations
20.
Holgado, Susana, E. Casado, Alejandro Olivé, & X Tena. (1999). Pronóstico y tratamiento de la enfermedad de Still del adulto. Medicina Clínica. 112(9). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026